Administration Both Tirzepatide and Semaglutide are administered via subcutaneous injection, typically once a week
Source: BioMedTracker, a service of Sagient Research ( This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription $32.99 / 30 days cancel any time Subscribe to this journal Receive 12 print issues and online access $259.00 per year only $21.58 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
What Are the Side Effects and Safety Considerations
It is expected to outpace Novo Nordisk's Ozempic a diabetes drug used so commonly to shed pounds that comedian Jimmy Kimmel joked about it at the Oscars and Wegovy, a version of the drug also known as semaglutide approved for weight loss in 2021
Compounded tirzepatide is very promising in weight management, and it is expected that the tirzepatide drug, Zepbound, will be approved for weight loss